Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial (vol 16, pg 31, 2016)

被引：0
|
作者：
Tapia, M. D.
Sow, S. O.
Lyke, K. E.
机构：
来源：
LANCET INFECTIOUS DISEASES | 2016年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [31] Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial
    Xu, Xiaowei
    Yu, Rui
    Xiao, Lanlan
    Wang, Jie
    Yu, Meihong
    Xu, Junjie
    Tan, Yajun
    Ma, Xiao
    Wu, Xiaoxin
    Lian, Jiangshan
    Huang, Kaizhou
    Ouyang, Xiaoxi
    Bi, Sheng
    Wu, Shipo
    Wang, Xiaoyan
    Jin, Jiandi
    Yu, Ling
    Zhang, Huafen
    Wei, Qi
    Shi, Jinfa
    Chen, Wei
    Li, Lanjuan
    ADVANCED SCIENCE, 2021, 8 (15)
  • [32] Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
    De Santis, Olga
    Audran, Regine
    Pothin, Emilie
    Warpelin-Decrausaz, Loane
    Vallotton, Laure
    Wuerzner, Gregoire
    Cochet, Camille
    Estoppey, Daniel
    Steiner-Monard, Viviane
    Lonchampt, Sophie
    Thieny, Anne-Christine
    Mayor, Carole
    Bailer, Robert T.
    Mbaya, Olivier Tshiani
    Zhou, Yan
    Ploquin, Aurelie
    Sullivan, Nancy J.
    Graham, Barney S.
    Roman, Francois
    De Ryck, Iris
    Ballou, W. Ripley
    Kieny, Marie Paule
    Moorthy, Vasee
    Spertini, Francois
    Genton, Blaise
    LANCET INFECTIOUS DISEASES, 2016, 16 (03): : 311 - 320
  • [33] Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial
    Ochoa-Azze, Rolando
    Chang-Monteagudo, Arturo
    Climent-Ruiz, Yanet
    Macias-Abraham, Consuelo
    Valenzuela-Silva, Carmen
    de los Angeles Garcia-Garcia, Maria
    Jerez-Barcelo, Yanet
    Triana-Marrero, Yenisey
    Ruiz-Villegas, Laura
    Dairon Rodriguez-Prieto, Luis
    Pablo Guerra-Chaviano, Pedro
    Sanchez-Ramirez, Belinda
    Hernandez-Garcia, Tays
    Orosa-Vazquez, Ivette
    Diaz-Hernandez, Marianniz
    Chiodo, Fabrizio
    Calcagno, Andrea
    Ghisetti, Valeria
    Rodriguez-Acosta, Mireida
    Noa-Romero, Enrique
    Enriquez-Puertas, Juliet
    Ortega-Leon, Darien
    Valdivia-Alvarez, Irinia
    Delahanty-Fernandez, Aurora
    Palenzuela-Diaz, Ariel
    Rodriguez-Noda, Laura
    Gonzalez-Mugica, Raul
    Valdes-Balbin, Yury
    Garcia-Rivera, Dagmar
    Verez-Bencomo, Vicente
    LANCET RESPIRATORY MEDICINE, 2022, 10 (08): : 785 - 795
  • [34] Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
    Lioznov, Dmitry
    Amosova, Irina A.
    Sheetikov, Savely
    Zornikova, Ksenia
    Serdyuk, Yana
    Efimov, Grigory
    Tsyferov, Mikhail
    Khmelevskii, Mikhail
    Afanasiev, Andrei
    Khomyakova, Nadezhda
    Zubkov, Dmitry
    Tikhonov, Anton
    Zhu, Tao
    Barreto, Luis
    Dzutseva, Vitalina
    PLOS ONE, 2023, 18 (03):
  • [35] Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone (vol 11, pg E1743, 2023)
    不详
    LANCET GLOBAL HEALTH, 2024, 12 (01): : E32 - E32
  • [36] Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
    Simpson, Eric L.
    Sinclair, Rodney
    Forman, Seth
    Wollenberg, Andreas
    Aschoff, Roland
    Cork, Michael
    Bieber, Thomas
    Thyssen, Jacob P.
    Yosipovitch, Gil
    Flohr, Carsten
    Magnolo, Nina
    Maari, Catherine
    Feeney, Claire
    Biswas, Pinaki
    Tatulych, Svitlana
    Valdez, Hernan
    Rojo, Ricardo
    LANCET, 2020, 396 (10246): : 255 - 266
  • [37] Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial
    Mo, Zhao-Jun
    Bi, Zhao-Feng
    Sheng, Wei
    Chen, Qi
    Huang, Teng
    Li, Ming-Qiang
    Cui, Xue-Lian
    Wangjiang, Ya-Hui
    Lin, Bi-Zhen
    Zheng, Feng-Zhu
    Sun, Guang
    Li, Ya-Fei
    Zheng, Ya
    Zhuang, Si-Jie
    Su, Ying-Ying
    Pan, Hui-Rong
    Huang, Shou-Jie
    Wu, Ting
    Zhang, Jun
    Xia, Ning-Shao
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [38] Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    Zhu, Fengcai
    Huang, Shoujie
    Liu, Xiaohui
    Chen, Qi
    Zhuang, Chunlan
    Zhao, Hui
    Han, Jinle
    Jaen, Anjuli May
    Do, Thai Hung
    Peter, Jonathan Grant
    Dorado, Alexander Gonzalez
    Tirador, Louie S.
    Zabat, Gelza Mae A.
    Villalobos, Ralph Elvi M.
    Gueco, Gemalyn Pineda
    Botha, Lauren Livia Greta
    Pertuz, Shirley Patricia Iglesias
    Tan, Jiaxiang
    Zhu, Kongxin
    Quan, Jiali
    Lin, Hongyan
    Huang, Yue
    Jia, Jizong
    Chu, Xiafei
    Chen, Junyu
    Chen, Yixin
    Zhang, Tianying
    Su, Yingying
    Li, Changgui
    Ye, Xiangzhong
    Wu, Ting
    Zhang, Jun
    Xia, Ningshao
    LANCET RESPIRATORY MEDICINE, 2023, 11 (12): : 1075 - 1088
  • [39] Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
    Zhu, Feng-Cai
    Wurie, Alie H.
    Hou, Li-Hua
    Liang, Qi
    Li, Yu-Hua
    Russell, James B. W.
    Wu, Shi-Po
    Li, Jing-Xin
    Hu, Yue-Mei
    Guo, Qiang
    Xu, Wen-Bo
    Wurie, Abdul R.
    Wang, Wen-Juan
    Zhang, Zhe
    Yin, Wen-Jiao
    Ghazzawi, Manal
    Zhang, Xu
    Duan, Lei
    Wang, Jun-Zhi
    Chen, Wei
    LANCET, 2017, 389 (10069): : 621 - 628
  • [40] Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo- controlled clinical trial
    Koren, Michael A.
    Lin, Leyi
    Eckels, Kenneth H.
    De La Barrera, Rafael
    Dussupt, Vincent
    Donofrio, Gina
    Sondergaard, Erica L.
    Mills, Kristin
    Robb, Merlin L.
    Lee, Christine
    Adedeji, Oluwaseun
    Keiser, Paul B.
    Curley, Justin M.
    Copeland, Nathanial K.
    Crowell, Trevor A.
    Hutter, Jack N.
    Hamer, Melinda J.
    Valencia-Ruiz, Anais
    Darden, Janice
    Peel, Sheila
    Amare, Mihret F.
    Mebrahtu, Tsedal
    Costanzo, Margaret
    Krebs, Shelly J.
    Gromowski, Gregory
    Jarman, Richard G.
    Thomas, Stephen J.
    Michael, Nelson L.
    Modjarrad, Kayvon
    LANCET INFECTIOUS DISEASES, 2023, 23 (10): : 1175 - 1185
12345